Soleno Therapeutics reports preliminary 2025 revenue of up to $191 million
Go back to Soleno Therapeutics reports preliminary 2025 revenue of up to $191 million| (NASDAQ: SLNO) | Delayed: 53.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.01 | 52 Week High | $ | |||
| Open | $53.01 | 52 Week Low | $ | |||
| Day High | $53.01 | P/E | N/A | |||
| Day Low | $53.01 | EPS | $ | |||
| Volume | 35,077 | |||||
